The Histone H3, Lysine 79 Methyltransferase Activity of DOT1L is Necessary for Murine Yolk Sac Erythro-Myeloid Progenitor Self-Renewal and Erythroblast Survival
Issue Date
2017-08-31Author
Malcom, Carrie
Publisher
University of Kansas
Format
102 pages
Type
Dissertation
Degree Level
Ph.D.
Discipline
Pathology & Laboratory Medicine
Rights
Copyright held by the author.
Metadata
Show full item recordAbstract
Disruptor of Telomere silencing 1-Like (DOT1L), is a histone 3, lysine 79 (H3K79) methyltransferase that has been implicated in multiple processes, including activation of transcription, regulation of the cell cycle, leukemogenesis, and mouse embryonic development. Previous studies found that Dot1L deficiency results in an erythropoietic defect, leading to lethal anemia at around mid-gestation (Feng et al., 2010, Blood). The precise molecular mechanism(s) by which DOT1L regulates embryonic hematopoiesis has not yet been elucidated, however. DOT1L is a large protein (1540aa), and it is involved in several, diverse processes. However, its only documented activity has been as an intrinsic, histone methyltransferase. Additional functional domains of the protein might be responsible for its diverse activities, including murine hematopoiesis. This study sought to determine whether the methyltransferase activity of DOT1L is essential for hematopoiesis. To test this hypothesis, a Dot1L methyltransferase mutant (Dot1L MM) mouse line was created. Using the Cas9/CRISPR system, a Dot1L point mutation was induced in cultured murine embryonic stem cells (mESC). These mESCs contained a wildtype allele, and the second had a single amino acid change in the methyltransferase domain of Dot1L, thereby eliminating its methyltransferase activity, but preserving the rest of the protein. These mutant mESCs were injected into blastocysts to produce chimeric mice. The chimeras possessing the methyltransferase mutation were back crossed onto the C57/BL6 background, producing male and female offspring heterozygous for the mutation. Through intercrosses of the F1 generation, it was found that the Dot1L MM mice display an embryonic lethality between embryonic days 10.5 and 13.5, similar to the Dot1L knockout mice, as reported in our previous studies. Additionally, ex vivo blood differentiation assays and extensively self-renewing erythroblast (ESRE) cultures were performed using E10.5 yolk sacs from Dot1L MM and knockout mice. The data showed that the Dot1L MM and knockout yolk sacs display similar phenotypes. In blood differentiation cultures, Dot1L knockout and MM yolk sac cells form the same types of hematopoietic colonies as in wildtype (erythroid, myeloid, and mixed), but there is a decrease in colony size and number compared to the wildtype. In the ESRE cultures, Dot1L knockout and MM yolk sac cells form significantly fewer ESREs and have increased cell death compared to wildtype. Strikingly, the cells in these cultures also exhibit a profound genomic instability, implicating DOT1L methyltransferase activity in maintenance of the genome as well as the viability of hematopoietic progenitors. These results suggest that the methyltransferase activity of DOT1L plays a predominant role in the activity of the protein as a whole, and is responsible for its function in facilitating early murine hematopoiesis.
Collections
- Dissertations [4660]
- KU Med Center Dissertations and Theses [464]
Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.